Published in Medicine and Law Weekly, October 14th, 2005
Data published on September 2, 2005, by Jopling et al. in the journal Science demonstrate that the microRNA known as miR-122 is required for HCV replication in mammalian cells. This study is the first to link endogenous expression of a specific microRNA with a major infectious disease, and suggests that antagonism of miR-122 may comprise a novel therapeutic strategy against...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly